Markel launches rare disease trial travel reimbursement scheme

Rare disease recruitment remains a significant challenge facing drug developers globally. Rare disease recruitment remains a significant challenge facing drug developers globally. Sponsors sign up to Markel’s programme to help cover the travel costs to improve recruitment in rare disease studies. Credit: New Africa / Shutterstock.com Markel Insurance has launched a reimbursement scheme to help boost enrolment for international trials evaluating rare disease therapies. The enhancement is purchased by trial sponsors and reimburses eligible travel-related expenses for approved participant travel to and from clinical trial sites. Clinical Trials: An Overview of Rescue Clinical Trials Go deeper with GlobalData The gold…

Source: Clinical Trials Arena